FDA Clearance Tracker · K221057
Viatrac 14 Plus Peripheral Dilatation Catheter
Last checked: Nov 20, 2026Latest source record: May 5, 2022 (this decision)Source: openFDAMethods & limitations
Decided
May 5, 2022
Substantially Equivalent
Time to decision
24 days
Received Apr 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K221057
- Device name
- Viatrac 14 Plus Peripheral Dilatation Catheter
- Applicant
- Abbott Vascular
- Applicant location
- Santa Clara, CA
- Received
- Apr 11, 2022
- Decided
- May 5, 2022
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1250
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LIT. The earliest in FDA's data is K803057, decided Jan 13, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K221057
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Abbott Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XACT Carotid Stent SystemPMA supplement
P040038-S043 · Decided Feb 7, 2024 · 225 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
- Perclose ProStyle Suture-Mediated Closure and Repair System, Perclose ProGlide Suture-Mediated Closure SystemPMA supplement
P960043-S118 · Decided Jun 2, 2023 · 256 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
K220634 · Decided Jun 30, 2022 · 118 days after receipt
Device type: Catheters, Transluminal Coronary Angioplasty, Percutaneous (LOX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.